Revvity, Inc. (LON:0KHE)
94.48
+0.16 (0.17%)
At close: Jul 17, 2025
Revvity Revenue
Revvity had revenue of $664.76M USD in the quarter ending March 30, 2025, with 2.28% growth. This brings the company's revenue in the last twelve months to $2.77B, up 1.62% year-over-year. In the year 2024, Revvity had annual revenue of $2.76B with 0.16% growth.
Revenue (ttm)
$2.77B
Revenue Growth
+1.62%
P/S Ratio
3.82
Revenue / Employee
$251.81K
Employees
11,000
Market Cap
8.18B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Revvity News
- 12 days ago - Revvity to Hold Earnings Call on Monday, July 28, 2025 - Business Wire
- 19 days ago - Peering Into Revvity's Recent Short Interest - Benzinga
- 6 weeks ago - Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows - Business Wire
- 2 months ago - Is the Market Bullish or Bearish on Revvity? - Benzinga
- 2 months ago - Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing - Business Wire
- 2 months ago - Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - Benzinga
- 2 months ago - Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy - Seeking Alpha
- 2 months ago - Revvity to Present at Upcoming Investor Conferences - Business Wire